Can a urine test help spot risky drinking in HIV-affected teens?

NCT ID NCT06903143

Completed Knowledge-focused Sponsor: Centre for Infectious Disease Research in Zambia Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This pilot study explores whether adding a urine biomarker test to standard alcohol screening can improve detection and treatment of harmful drinking among HIV-affected adolescents and young adults in Lusaka, Zambia. Sixty participants aged 16–24 will receive a brief counseling session and, if needed, a referral to more intensive therapy. Researchers will track how many complete each step and interview participants and staff to assess the program's feasibility and acceptability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Screening, brief intervention, and referral to treatment (SBIRT) program
What this could lead to: If successful, this approach could improve alcohol screening and reduce harmful drinking among HIV-affected youth in resource-limited settings.
What could go wrong: This is a small pilot study with only 60 participants, so results may not apply broadly. The program's effectiveness and feasibility are still being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL

Contacts and locations

Locations

CIDRZ

Lusaka, Lusaka Province, 10101, Zambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.